Skip to main content
Premium Trial:

Request an Annual Quote

Alex Titomirov, Andrew Whiteley, Peter Staple

Premium

InforMax of Bethesda, Md., has found a replacement for founder and former CEO Alex Titomirov, who announced his plans to step down in October. Andrew Whiteley, previously vice president of bioinformatics at Amersham Biosciences, will succeed Titomirov as chairman, CEO, and president. Titomirov also resigned from the company’s board.

 

Burlingame, Calif.-based systems biology company BioSeek has tapped Peter Staple as CEO. Staple, most recently executive VP, chief administrative officer, and general counsel at Johnson & Johnson subsidiary ALZA, will be responsible for leading the company as it begins to apply its proprietary biology and informatics technology platforms commercially. Staple was also elected to BioSeek’s board of directors.

Filed under

The Scan

Study Finds Sorghum Genetic Loci Influencing Composition, Function of Human Gut Microbes

Focusing on microbes found in the human gut microbiome, researchers in Nature Communications identified 10 sorghum loci that appear to influence the microbial taxa or microbial metabolite features.

Treatment Costs May Not Coincide With R&D Investment, Study Suggests

Researchers in JAMA Network Open did not find an association between ultimate treatment costs and investments in a drug when they analyzed available data on 60 approved drugs.

Sleep-Related Variants Show Low Penetrance in Large Population Analysis

A limited number of variants had documented sleep effects in an investigation in PLOS Genetics of 10 genes with reported sleep ties in nearly 192,000 participants in four population studies.

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.